In vitro wound healing of tumor cells: inhibition of cell migration by selected cytotoxic alkaloids

Enhanced Healing Activity of Burn Wound Infection by Dextran-HA Hydrogel Enriched with Sanguinarine

(2018) Qiyu Zhu et al.   Biomaterials Science

TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays

(2018) Tobias Gebäck et al.   BIOTECHNIQUES

Anticancer potential of sanguinarine for various human malignancies

(2017) Iman W Achkar et al.   Future Medicinal Chemistry

Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cells

(2017) Zhi Hong Zhang et al.   PHYTOTHERAPY RESEARCH

Cytoskeletal interference – A new mode of action for the anticancer drugs camptothecin and topotecan

(2016) Xiaojuan Wang et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Interference of Selected Cytotoxic Alkaloids with the Cytoskeleton: An Insight into Their Modes of Action

(2016) Xiaojuan Wang et al.   MOLECULES

Colchicine: Old and New

(2015) Anastasia Slobodnick et al.   AMERICAN JOURNAL OF MEDICINE

A novel synthetic compound exerts effective anti-tumour activity in vivo via the inhibition of tubulin polymerisation in A549 cells

(2015) Jun Yan et al.   BIOCHEMICAL PHARMACOLOGY

Chelidonine suppresses migration and invasion of MDA-MB-231 cells by inhibiting formation of the integrin-linked kinase/PINCH/α-parvin complex

(2015) OKHWA KIM et al.   Molecular Medicine Reports

Microtubule-targeting agents are clinically successful due to both mitotic and interphase impairment of microtubule function

(2014) Jessica J. Field et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Multiple mechanisms of cell death induced by chelidonine in MCF-7 breast cancer cell line

(2014) Sakineh Kazemi Noureini et al.   CHEMICO-BIOLOGICAL INTERACTIONS

Alkaloids as Important Scaffolds in Therapeutic Drugs for the Treatments of Cancer, Tuberculosis, and Smoking Cessation

(2014) Prasat Kittakoop et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Recent developments in tubulin polymerization inhibitors: An overview

(2014) Ramandeep Kaur et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Omacetaxine mepesuccinate in chronic myeloid leukemia

(2014) Omar Al Ustwani et al.   EXPERT OPINION ON PHARMACOTHERAPY

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

(2014) L Molife et al.   Journal of Hematology & Oncology

Sanguinarine protects against pressure overload-induced cardiac remodeling via inhibition of nuclear factor-κB activation

(2014) WEI DENG et al.   Molecular Medicine Reports

The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages

(2012) Xiaofeng Niu et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The Role of Microtubules and Their Dynamics in Cell Migration

(2012) Anutosh Ganguly et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and Bcl-2 family proteins in human hepatoma SMMC-7721 Cell

(2011) Zheng-fu Zhang et al.   ARCHIVES OF PHARMACAL RESEARCH

Chelerythrine perturbs lamellar actomyosin filaments by selective inhibition of myotonic dystrophy kinase-related Cdc42-binding kinase

(2011) Ivan Tan et al.   FEBS LETTERS

Drugs that target dynamic microtubules: A new molecular perspective

(2011) Richard A. Stanton et al.   MEDICINAL RESEARCH REVIEWS

Inhibition of Cell Migration and Cell Division Correlates with Distinct Effects of Microtubule Inhibiting Drugs

(2010) Hailing Yang et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Microtubule-binding agents: a dynamic field of cancer therapeutics

(2010) Charles Dumontet et al.   NATURE REVIEWS DRUG DISCOVERY

Homoharringtonine, omacetaxine mepesuccinate, and chronic myeloid leukemia circa 2009

(2009) Alfonso Quintás-Cardama et al.   CANCER

Integrins in cell migration - the actin connection

(2009) M. Vicente-Manzanares et al.   JOURNAL OF CELL SCIENCE